載入...
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform
Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate recombinant MVA vectors from chemically synthesized D...
Na minha lista:
| 發表在: | Res Sq |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Journal Experts
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373143/ https://ncbi.nlm.nih.gov/pubmed/32702732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-40198/v1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|